ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Woburn, Mass.-based polyhydroxyalkanoate polymer maker Metabolix has agreed to sell its core PHA business to South Korea’s CJ CheilJedang for $10 million. The purchase includes intellectual property, platform microbial strains for fermenting PHA, and laboratory facilities. Last month, the company, strapped for cash, said it was winding down the PHA business to focus on its Yield10 Bioscience crop technology. Earlier in the year, CJ and Metabolix announced they were considering the construction of a 10,000-metric-ton-per-year PHA plant at CJ’s Fort Dodge, Iowa, facility, where the firm already makes lysine.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X